TY - JOUR T1 - The predominance of Newcastle disease virus genotype VII: genome diversity or poor cross-immunity of non-matched vaccines TT - JF - vacres JO - vacres VL - 8 IS - 2 UR - http://vacres.pasteur.ac.ir/article-1-279-en.html Y1 - 2021 SP - 4 EP - 16 KW - Newcastle disease virus KW - vaccine KW - genetic divergence KW - immune responses N2 - Introduction: The virulent Newcastle disease virus (NDV) strains cause an economically important infectious disease in poultry. The common vaccination program with genotype II NDV strains is routinely practiced to provide a better protection level against Newcastle disease (ND). Nevertheless, the emergence of new antigenic and genetic variants within the circulating NDVs raises the importance of improved control strategies. The genotype VII NDV is associated with many of the most recent outbreaks of the disease worldwide. Methods: We evaluated the impacts of genetic divergence between the genotypes II and VII on the immunity against NDV to choose a suitable vaccine virus candidate by focusing on the F and HN proteins. Comparative bioinformatics analyses based on B- and T-cell epitopes binding affinity, protein secondary structure and physicochemical properties predictions were applied for genotypes II and VII. Results: Although the results showed more differences in HN protein than F protein, there was no major difference between the predicted antigenicity values, epitope regions, affinity binding to MHC-I and MHC-II, secondary structures, surface accessibility, and stability of these immunogens between genotypes II and VII. Conclusion: The results suggest that genotype II-based live vaccines can induce immune responses against NDV; however, an inactivated vaccine formulated by genotype VII should be considered in combination with the traditional live vaccine to provide better protection in controlling programs against ND. M3 10.52547/vacres.8.2.4 ER -